Clene Inc.

NASDAQ:CLNN

4.54 (USD) • At close March 11, 2025
Bedrijfsnaam Clene Inc.
Symbool CLNN
Munteenheid USD
Prijs 4.54
Beurswaarde 37,799,309
Dividendpercentage 0%
52-weken bereik 3.82 - 9.8
Industrie Biotechnology
Sector Healthcare
CEO Mr. Robert Etherington MBA
Website https://clene.com

An error occurred while fetching data.

Over Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof

Vergelijkbare Aandelen

Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc.

FENC

6.4 USD

Savara Inc. logo

Savara Inc.

SVRA

2.55 USD

Compugen Ltd. logo

Compugen Ltd.

CGEN

1.62 USD

High Tide Inc. logo

High Tide Inc.

HITI

2.3 USD

NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE

10.36 USD

Quipt Home Medical Corp. logo

Quipt Home Medical Corp.

QIPT

2.5 USD

Vor Biopharma Inc. logo

Vor Biopharma Inc.

VOR

0.887 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

0.762 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)